Study for rare gut cancer types with targeted treatment
Part of Cancer, Digestive system clinical trials.
This study looks at rare types of gastrointestinal (GI) cancer and may match you to a targeted treatment. It also collects blood and other samples to better understand your cancer and help researchers learn what works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a rare GI cancer type (for example, with BRAF V600E, MSI-H, HER2, or similar markers)
- Your care team plans targeted treatment for your cancer
- You can understand written study information and consent to take part
- You agree to provide samples (like blood) for research studies
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial collects blood and tumor tissue from adults with cancer to help researchers study gastrointestinal cancers. If you’re eligible, your participation mainly involves donating samples for research purposes.
This study is looking at people with rare cancers affecting the female reproductive system. It may help researchers learn more about how these cancers behave and how best to follow patients over time.
This study looks at stomach (gastric) and esophagus cancer, using clinical information and tissue samples. It may help researchers better understand these cancers and improve future care.
This study looks at stomach (or stomach–esophagus junction) cancer tissue, treatment details, and patient-reported experiences to better predict how you may respond to standard chemotherapy. It may help personalize future treatment by identifying markers that connect your tumor environment and your expected outcomes.
This study collects blood and tumor tissue samples from patients with certain untreated cancers to help researchers develop and improve tests. You may be eligible if you have one of the listed cancer types and have not yet started treatment.
This trial looks at tiny pieces of DNA found outside cells in stomach tissue to better understand how gastric (stomach) cancer starts and progresses. It may help future patients by improving how doctors study stomach cancer from biopsy and surgical samples.
Hear when a new Cancer of Gastrointestinal Tract trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.